(Q40536032)

21 September 2017

1 reference

title

The 'peptoid' approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides (English)

1 reference

21 September 2017

Horwell DC

1

1 reference

21 September 2017

publication date

1 April 1995

1 reference

21 September 2017

published in

Trends in Biotechnology

1 reference

21 September 2017

volume

13

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

132-134

1 reference

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988923-4

7 January 2021

A nonpeptidyl growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988923-4

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988923-4

7 January 2021

Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988923-4

7 January 2021

Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988923-4

7 January 2021

PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988923-4

7 January 2021

Cholecystokinin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988923-4

7 January 2021

10.1016/S0167-7799(00)88923-4

Identifiers

DOI

1 reference

21 September 2017

1 reference